TTNP - Titan Pharmaceuticals, Inc. (de)
IEX Last Trade
5.97
0.307 5.134%
Share volume: 148,836
Last Updated: Fri 30 Aug 2024 05:46:57 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$5.66
0.31
5.41%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | |
---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
Report Date | 2022-05-16 | 2022-08-11 | 2022-11-14 | 2023-03-31 | 2023-05-15 | |
Assets | ||||||
Total Assets | 10.318 M | 8.319 M | 6.276 M | 4.058 M | 2.168 M | |
Current Assets | 9.633 M | 7.713 M | 5.747 M | 3.603 M | 1.785 M | |
Inventories | 293.000 K | 469.000 K | 460.000 K | 106.000 K | 106.000 K | |
Other Current Assets | 749.000 K | 544.000 K | 512.000 K | 314.000 K | 406.000 K | |
Short Term Investments | 749.000 K | 544.000 K | 512.000 K | 314.000 K | 406.000 K | |
Total Receivables | 218.000 K | 101.000 K | 49.000 K | 36.000 K | 8.000 K | |
Current Cash | 8.138 M | 6.420 M | 4.450 M | 2.937 M | 1.136 M | |
Total Non-current Assets | 685.000 K | 606.000 K | 529.000 K | 455.000 K | 383.000 K | |
Property Plant Equipment | 368.000 K | 317.000 K | 269.000 K | 224.000 K | 181.000 K | |
Other Assets | 48.000 K | 48.000 K | 48.000 K | 48.000 K | 48.000 K | |
Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Liabilities and shareholders’ equity | ||||||
Total Liabilities and shareholders’ equity | 10.318 M | 8.319 M | 6.276 M | 4.058 M | 2.168 M | |
Total liabilities | 2.436 M | 2.652 M | 2.726 M | 2.695 M | 2.480 M | |
Total current liabilities | 2.278 M | 2.524 M | 2.630 M | 2.630 M | 2.447 M | |
Accounts Payable | 468.000 K | 443.000 K | 812.000 K | 695.000 K | 567.000 K | |
Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 7.882 M | 5.667 M | 3.550 M | 1.363 M | -312.000 K | |
Common stock | 10.729 M | 13.692 M | 14.629 M | 14.686 M | 15.016 M | |
Retained earnings | -378.595 M | -381.057 M | -383.695 M | -386.261 M | -387.936 M |